KYMR - Kymera Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$119.93
DETAILS
HIGH:
$138.00
LOW:
$106.00
MEDIAN:
$119.00
CONSENSUS:
$119.93
UPSIDE:
52.02%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 100.0% |
| EBIT Margin | -794.3% |
| EBITDA Margin | -773.1% |
| Operating Margin | -891.3% |
| Pretax Margin | -795.0% |
| Cont. Ops Margin | -795.0% |
| Net Margin | -794.4% |
| Bottom Line Margin | -794.4% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 10.47 |
| Quick Ratio | 10.47 |
| Solvency Ratio | -1.858 |
| Cash Ratio | 4.29 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-21.09
Peers avg: 17.9
|
| PEG Ratio | -0.89 |
| Forward PEG | -0.89 |
| Price/Book | 4.16 |
| Price/Sales | 167.51 |
| Price/FCF | -28.02 |
| Price/Op Cash Flow | -28.20 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0472 |
| Debt/Equity | 0.0521 |
| Debt/Capital | 0.0495 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.10 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.06 |
| Operating Cash Flow Ratio | -2.799 |
| Operating Cash Flow/Sales | -594.1% |
| Free Cash Flow/Operating Cash Flow | 100.6% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -21.64 |
| Interest Coverage | -1403.2129 |
| Short-Term Operating Cash Flow Coverage | -16.93 |
| Operating Cash Flow Coverage | -2.83 |
| Capital Expenditure Coverage | -160.73 |
| Dividend + Capital Expenditure Coverage | -160.73 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.46 |
| EPS | -3.690 |
| Debt/Share | 0.9776 |
| Cash/Share | 10.05 |
| Book Value/Share | 18.72 |
| Tangible BV/Share | 18.72 |
| Equity/Share | 18.72 |
| Operating Cash Flow/Share | -2.760 |
| Capital Expenditure/Share | 0.017 |
| FCF/Share | -2.777 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.999 |
| Earnings Before Tax/EBIT | 0.892 |
| Price/Fair Value | 4.16 |
| Debt/Market Cap | 0.0021 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -20.76 |